the new ONCE-DAILY antiretroviral drug called Viread

There's a lot of excitement about the new ONCE-DAILY antiretroviral drug called Viread (VEER-ee-ad)...from Gilead Sciences.

It's the first HIV drug approved in the U.S. this year...an expanded access programme is being put together for Canada.

Viread (tenofovir) is the first nucleoTIDE reverse transcriptase inhibitor. It's similar in structure to the nucleoSIDE reverse transcriptase inhibitors...but might be more active.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote